Mr. Shaun Flanagan:

Just one clarification Mr. Hennessy. The drugs group recommendation is often quite different to the recommendation from the National Centre for Pharmoeconomics, NCPE, because commercial negotiations may have taken place. There is a step through the process and the drugs group has a mixed membership with 50% consisting of clinicians, senior clinical leaders within the HSE and a clinician from the hospital acute system, economists and various experts like that.